In a patient with chest pain who has an initial positive high‑sensitivity troponin, a normal electrocardiogram, a normal echocardiogram, and a subsequent negative repeat troponin, what is the appropriate management?

Management of Chest Pain with Initial Positive Troponin, Normal ECG/Echo, and Negative Repeat Troponin

This patient meets criteria for low-risk accelerated discharge from the emergency department based on serial negative high-sensitivity troponin testing, non-ischemic ECG, and normal echocardiogram, with mandatory outpatient cardiology follow-up within 1–2 weeks. 1

Immediate Risk Stratification

• The combination of a non-ischemic ECG and negative serial high-sensitivity troponin at presentation and 2 hours predicts <1% 30-day major adverse cardiovascular events (MACE), allowing safe early discharge. 1
• The initial positive troponin followed by a negative repeat indicates either:
  • Laboratory variation near the assay's detection threshold
  • Transient minor myocardial injury that has resolved
  • A false-positive result 2
• Normal echocardiogram excludes significant structural heart disease (e.g., severe LV dysfunction, regional wall motion abnormalities, valvular disease) that would elevate baseline troponin or indicate acute injury. 3

Discharge Criteria (All Must Be Met)

• Serial troponins remain below the 99th percentile with no rising pattern (absolute change <5 ng/L for most assays). 2
• Non-ischemic ECG: no ST-segment depression ≥0.5 mm, no transient ST-elevation, no new T-wave inversions in ≥2 contiguous leads. 3, 2
• No ongoing chest pain at the time of the second troponin measurement. 2
• Low clinical risk score: TIMI 0–1, HEART score <3, or EDACS <16. 1, 3
• Hemodynamically stable: no hypotension, no signs of acute heart failure. 2

What NOT to Do Before Discharge

• Do not routinely perform stress testing, coronary CT angiography, or myocardial perfusion imaging before discharge in low-risk patients in whom acute MI has been ruled out—these tests do not reduce 30-day MACE. 1
• Do not discharge based on a single troponin result alone, even if negative; serial testing is mandatory. 2
• Do not attribute the initial positive troponin to chronic conditions (e.g., chronic kidney disease) without confirming stability on serial testing. 2

Mandatory Outpatient Follow-Up

• Arrange cardiology follow-up within 1–2 weeks for all discharged patients. 1, 2
• If outpatient follow-up is unavailable or uncertain, consider further testing or observation before discharge rather than discharging without a safety net. 1
• Outpatient stress testing or coronary CT angiography may be arranged at the discretion of the outpatient cardiologist if the patient has risk factors or atypical features, but this is not required before ED discharge. 1, 3

High-Risk Features That Would Change Management

If any of the following were present, admission would be required instead of discharge:

• Dynamic ECG changes during observation (new ST-depression, transient ST-elevation, evolving T-wave inversions). 3, 2
• Recurrent chest pain during the observation period. 2
• Rising troponin trend on serial testing (absolute increase >7–10 ng/L or >20% relative change when values are elevated). 3, 2
• Hemodynamic instability (hypotension, pulmonary edema, arrhythmias). 2

Pitfalls to Avoid

• Do not rely on point-of-care troponin assays for definitive rule-out; use central laboratory high-sensitivity assays. 2
• Do not wait 3–6 hours for a repeat troponin when validated 0-hour/1-hour or 0-hour/2-hour protocols are available and appropriate. 2
• Do not assume the normal echocardiogram excludes coronary artery disease—it only excludes significant structural abnormalities and acute regional dysfunction. 3
• Do not discharge without confirming outpatient follow-up arrangements, as patients lost to follow-up have worse outcomes. 1

Medication at Discharge

• Aspirin 81 mg daily is reasonable for secondary prevention if the patient has cardiovascular risk factors, though acute antiplatelet therapy (e.g., dual antiplatelet therapy) is not indicated when MI is ruled out. 1
• Continue or optimize cardiovascular risk factor management (statins, antihypertensives, diabetes control) as appropriate. 1

Documentation Requirements

• Document the specific troponin values, timing, and assay used (including the 99th percentile threshold for your laboratory). 2
• Record the risk score calculated (TIMI, HEART, or EDACS) to justify the low-risk designation. 1, 3
• Confirm that outpatient follow-up has been arranged and communicated to the patient. 1